MedTrace Logo

Change of Range of Motion of TMJ After Correction of Pelvic a Symmetry in Women With Cyclic Pelvic Pain

NCT04077788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-09-21

No results posted yet for this study

Summary

Clinical experiences have shown that significant pain regression during a menstrual cycle has been often achieved by the use of spinal manipulative therapy (SMT) indicated in women with primary dysmenorrhea with coexisting functional disorders of lumbosacral (LS) spine. Namely, by activation of the nociceptive and vegetative system, LS spine disorders, before all segmental dysfunction and degenerative changes, can induce referred pain and reflex disturbances of pelvic organs (somatovisceral reflexes). Since significant improvement or disappearance of pain during a menstrual cycle is often achieved with adequate therapy of coexisting vertebral disorders in women with primary dysmenorrhea, it is important to recognise latent or manifest vertebral disorders in dysmenorrheic women using clinical examination (Grgić, 2009).

Conditions

  • Pelvic Pain

Interventions

OTHER

muscle energy technique

Muscle energy technique: 1. Application of MET for bone of pelvis: I) Pubis: 1. Cranial Os pubis. 2. Caudal os pubis. II) ileum: 1. Anterior ileum. 2. Posterior ileum. 3. External Rotation (In flare) Lesion. 4. Internal Rotation (Out flare) Lesion. III) sacrum: 1. Forward torsion of sacrum. 2. Backward torsion of sacrum. 2. Muscle energy technique for specific muscles of pelvis and spine: 1. Stretch of the Psoas Major. 2. Stretch of the paravertebral muscle. 3. Stretch of the piriforms.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-08
Primary Completion
2020-08-01
Completion
2020-08-11

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04077788 on ClinicalTrials.gov